Knockdown of RCK/p54 expression by RNAi inhibits proliferation of human colorectal cancer cells in vitro and in vivo

Cancer Biology and Therapy

Volumn 7, Issue 10, 2008, Pages 1669-1676

  Lin, Fang ^a   Wang, Rui ^a   Shen, Jian Jun ^a   Wang, Xi ^a   Gao, Ping ^a   Dong, Ke ^a   Zhang, Hui Zhong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

APC; Colorectal cancer; DEAD box protein; Gene therapy; RCK p54; RNA interference; Wnt signaling

Indexed keywords

APC PROTEIN; DEAD BOX PROTEIN; PLASMID VECTOR; PROTEIN P54; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR 7; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER INHIBITION; CELL COUNT; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN TARGETING; RNA INTERFERENCE; TRANSCRIPTION INITIATION;

EID: 54349107863     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.7.10.6660     Document Type: Article

References (33)

1. Huerta S. Recent advances in the molecular diagnosis and prognosis of colorectal cancer. Expert Rev Mol Diagn 2008; 8:277-88.
2. Chua YJ, Zalcberg JR. Progress and challenges in the adjuvant treatment of stage II and III colon cancers. Expert Rev Anticancer Ther 2008; 8:595-604.
3. Akao Y, Marukawa O, Morikawa H, Nakao K, Kamei M, Hachiya T, Tsujimoto Y. The rck/p54 candidate proto-oncogene product is a 54-kilodalton D-E-A-D box protein differentially expressed in human and mouse tissues. Cancer Res 1995; 55:3444-9.
4. Hashimoto K, Nakagawa Y, Morikawa H, Niki M, Egashira Y, Hirata I, Katsu K, Akao Y. Co-overexpression of DEAD box protein rck/p54 and c-myc protein in human colorectal adenomas and the relevance of their expression in cultured cell lines. Carcinogenesis 2001; 22:1965-70.
5. Nakagawa Y, Morikawa H, Hirata I, Shiozaki M, Matsumoto A, Maemura K, Nishikawa T, Niki M, Tanigawa N, Ikegami M, Katsu K, Akao Y. Overexpression of rck/p54, a DEAD box protein, in human colorectal tumours. Br J Cancer 1999; 80:914-7.
6. Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, Si W, Park JK, Wang H, Peng Y, Jiang W, He TC. Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets 2004; 4:653-71.
7. Suehiro Y, Wong CW, Chirieac LR, Kondo Y, Shen L, Webb CR, Chan YW, Chan AS, Chan TL, Wu TT, Rashid A, Hamanaka Y, Hinoda Y, Shannon RL, Wang X, Morris J, Issa JP, Yuen ST, Leung SY, Hamilton SR. Epigenetic-Genetic Interactions in the APC/WNT, RAS/RAF and P53 Pathways in Colorectal Carcinoma. Clin Cancer Res 2008; 14:2560-9.
8. Kámory E, Olasz J, Csuka O. Somatic APC Inactivation Mechanisms in Sporadic Colorectal Cancer Cases in Hungary. Pathol Oncol Res 2008; 14:51-6.
9. Wang JY, Hsieh JS, Lu CY, Yu FJ, Wu JY, Chen FM, Huang CJ, Lin SR. The differentially mutational spectra of the APC, K-ras, and p53 genes in sporadic colorectal cancers from Taiwanese patients. Hepatogastroenterology 2007; 54:2259-65.
10. Akao Y, Yoshida H, Matsumoto K, Matsui T, Hogetu K, Tanaka N, Usukura J. A tumour-associated DEAD-box protein, rck/p54 exhibits RNA unwinding activity toward c-myc RNAs in vitro. Genes Cells 2003; 8:671-6.
11. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002; 111:241-50.
12. Labianca R, Beretta G, Gatta G, de Braud F, Wils J. Colon cancer 2004; 51:145-70.
13. Akao Y, Matsumoto K, Ohguchi K, Nakagawa Y, Yoshida H. Human DEAD-box/RNA unwindase rck/p54 contributes to maintenance of cell growth by affecting cell cycle in cultured cells. Int J Onco 2006; l29:41-8.
14. Miyaji K, Nakagawa Y, Matsumoto K, Yoshida H, Morikawa H, Hongou Y, Arisaka Y, Kojima H, Inoue T, Hirata I, Katsu K, Akao Y. Overexpression of a DEAD box/RNA helicase protein, rck/p54, in human hepatocytes from patients with hepatitis C virus-related chronic hepatitis and its implication in hepatocellular carcinogenesis. J Viral Hepat 2003; 10:241-8.
15. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes 2001; 15:188-200.
16. Bakalova R. RNA interference - about the reality to be exploited in cancer therapy. Methods Find Exp Clin Pharmacol 2007; 29:417-21.
17. Waseem T. RNA interference: a potential revolution in disease therapy. J Coll Physicians Surg Pak 2006; 16:491-2.
18. Bagasra O. RNAi as an antiviral therapy. Expert Opin Biol Ther 2005; 5:1463-74.
19. Manoharan M. RNA interference and chemically modified siRNAs. Nucleic Acids Res Suppl 2003; 3:115-6.
20. Arendt CW, Tang G, Zilberstein A. Vector systems for the delivery of small interfering RNAs: managing the RISC. ChemBioChem 2003; 4:1129-36.
21. Kwak YD, Koike H, Sugaya K. RNA interference with small hairpin RNAs transcribed from a human U6 promoter-driven DNA vector. J Pharmacol Sci 2003; 93:214-7.
22. Yuan J, Wang X, Zhang Y, Hu X, Fei J, Li N. Mammalian Pol III promoter H1 can transcribe shRNA inducing RNAi in chicken cells. Mol Biol Rep 2006; 33:33-41.
23. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000; 103:311-20.
24. Segditsas S and Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 2006; 25:7531-7.
25. Humphries A, Wright NA. Colonic crypt organization and tumorigenesis. Nat Rev Cancer 2008; 8:415-24.
26. Gan XQ, Wang JY, Xi Y, Wu ZL, Li YP, Li L. Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction. J Cell Biol 2008; 180:1087-100.
27. Wilkins JA, Sansom OJ. C-Myc is a critical mediator of the phenotypes of Apc loss in the intestine. Cancer Res 2008; 68:4963-6.
28. Udhayakumar G, Jayanthi V, Devaraj N, Devaraj H. Interaction of MUC1 with betacatenin modulates the Wnt target gene cyclinD1 in H. pylori-induced gastric cancer. Mol Carcinog 2007; 46:807-17.
29. Buchanan FG, DuBois RN. Connecting COX-2 and Wnt in cancer. Cancer Cell 2006; 9:6-8.
30. Yuan D, Liu L, Gu D. Transcriptional regulation of livin by beta-catenin/TCF signaling in human lung cancer cell lines. Mol Cell Biochem 2007; 306:171-8.
31. Zhu HX, Zhang G, Wang YH, Zhou CQ, Bai JF, Xu NZ. Indomethacin induces apoptosis through inhibition of survivin regulated by beta-catenin/TCF4 in human colorectal cancer cells. Ai Zheng 2004; 23:737-41.
32. Pishvaian MJ, Byers SW. Biomarkers of WNT signaling. Cancer Biomark 2007; 3:263-74.
33. Segditsas S and Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 2006; 25:7531-7.